Global Traumatic Brain Injuries Treatment Market
Taille du marché en milliards USD
TCAC :
% 
USD
3.67 Billion
USD
6.13 Billion
2024
2032
 Période de prévision |
2025 –2032 |
 Taille du marché (année de référence) |
USD 3.67 Billion |
 Taille du marché (année de prévision) |
USD 6.13 Billion |
 TCAC |
% |
| Principaux acteurs du marché |
|
Global Traumatic brain injuries treatment Market, By Treatment (Immediate Emergency Care, Medications, Surgery), Route of Administration (Parenteral, Oral), Patient Age (Children, Teenager, Elder), Gender (Male, Female), Cause of Injury (Falls, Motor Vehicle Traffic, Sports, Others), End Users (Hospitals, Neurology Clinics, Independent Pharmacies, Others) – Industry Trends and Forecast to 2030.
Traumatic Brain Injuries Treatment Market Analysis and Size
The traumatic brain injuries treatment drugs market growth is driven by primary factors such as extensive surgical procedures which are required for the treatment and correction of these injuries. Furthermore, various innovations and advancements in technologies, extensive research and development activities, and a high volume of clinical trials being conducted for the development of traumatic brain injuries are also expected to drive the growth of the traumatic brain injuries treatment market in the forecast period of 2023-2030. However, lack of awareness amongst various individuals and consumers of this treatment in the underdeveloped economies, restrains the growth of traumatic brain injuries treatment market in the forecast period of 2023-2030. Also, high price and delayed diagnostic conclusions will challenge market growth in the above-mentioned forecast period. In addition, rising cases of car accidents and injuries caused due to sports will create ample opportunities for the traumatic brain injuries treatment market in the above-mentioned forecast period.
Data Bridge Market Research analyses that the global traumatic brain injuries treatment market which was USD 3.46 billion in 2022, and would rocket up to USD 5.53 billion by 2030, and is expected to undergo a CAGR of 6.20% during the forecast period. “Hospitals” is expected to dominate the end-user segment of the traumatic brain injuries treatment market owing to the growing demand for drug. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Traumatic Brain Injuries Treatment Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015-2020) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Treatment (Immediate Emergency Care, Medications, Surgery), Route of Administration (Parenteral, Oral), Patient Age (Children, Teenager, Elder), Gender (Male, Female), Cause of Injury (Falls, Motor Vehicle Traffic, Sports, Others), End Users (Hospitals, Neurology Clinics, Independent Pharmacies, Others) |
|
Pays couverts |
États-Unis, Canada et Mexique en Amérique du Nord, Allemagne, France, Royaume-Uni, Pays-Bas, Suisse, Belgique, Russie, Italie, Espagne, Turquie, Reste de l'Europe en Europe, Chine, Japon, Inde, Corée du Sud, Singapour, Malaisie, Australie, Thaïlande, Indonésie, Philippines, Reste de l'Asie-Pacifique (APAC) en Asie-Pacifique (APAC), Arabie saoudite, Émirats arabes unis, Afrique du Sud, Égypte, Israël, Reste du Moyen-Orient et de l'Afrique (MEA) en tant que partie du Moyen-Orient et de l'Afrique (MEA), Brésil, Argentine et Reste de l'Amérique du Sud en tant que partie de l'Amérique du Sud. |
|
Acteurs du marché couverts |
Zimmer Biomet (États-Unis), Neuren Pharmaceuticals (Australie), Teva Pharmaceutical Industries Ltd. (Israël), Medicortex Finland Oy (Finlande), AMARANTUS BIOSCIENCE HOLDINGS, INC. (États-Unis), Stemedica Cell Technologies, Inc. (États-Unis), BANYAN BIOMARKERS, INC. (États-Unis), BioDirection (États-Unis), QuesGen Systems, Inc. (États-Unis), Neural Analytics, Inc. (États-Unis), Oculogica, VASOPHARM (États-Unis), Johnson & Johnson Services Inc. (États-Unis), Smith & Nephew (Royaume-Uni), Stryker (États-Unis), Medtronic (États-Unis), Bioretec Ltd. (Finlande), B.Braun Melsungen AG (Allemagne), Arthrex, Inc. (États-Unis), Wright Medical Group NV (États-Unis), NuVasive Inc. (États-Unis), Advance Orthopaedic Solutions (États-Unis), Arthrosurface (États-Unis), CONMED Corporation (États-Unis), entre autres |
|
Opportunités de marché |
|
Définition du marché
Les traitements des traumatismes crâniens font partie des diverses méthodes thérapeutiques disponibles dans le secteur de la santé, développées pour le traitement des traumatismes crâniens de différents degrés. Le traitement fait principalement appel à des produits pharmaceutiques doux conçus pour le traitement des lésions de moindre gravité.
Dynamique du marché mondial du traitement des traumatismes crâniens
Conducteurs
- Augmentation des cas de lésions cérébrales
Les signes et symptômes d'un traumatisme crânien peuvent se développer après une blessure à la tête ou peuvent parfois prendre plusieurs jours ou semaines pour se manifester. Il existe trois niveaux de traumatisme crânien : léger, modéré et grave. Un patient qui subit une blessure mineure souffre d'une commotion cérébrale temporaire, qui dans de rares cas peut entraîner des anomalies cérébrales fonctionnelles durables. Cela stimule la croissance du marché.
En raison de l’augmentation des cas de lésions cérébrales dus à davantage d’accidents, de chutes, de traumatismes contondants et d’autres lésions physiques du cerveau, ainsi que des investissements continus réalisés dans l’établissement et la croissance du marché du traitement des lésions cérébrales traumatiques.
- Croissance démographique croissante
En raison de la croissance démographique et de l'augmentation du revenu par habitant, qui ont modifié la demande des consommateurs pour des produits et équipements hautement sophistiqués et technologiquement avancés, le marché des traumatismes crâniens a connu une croissance dans tous les segments et toutes les zones géographiques. Cela a servi de force motrice au marché. En outre, le nombre de patients nécessitant un traitement pour des lésions cérébrales traumatiques a augmenté en raison de l'augmentation des accidents de la route, des blessures liées au sport, des chutes, des blessures par balle et des blessures dues à la violence domestique. L'une des principales raisons de l'augmentation de la demande de chirurgie cérébrale est le vieillissement de la population et les problèmes neurologiques qu'elle rencontre en vieillissant.
- Augmentation du nombre d'essais cliniques sur le traitement des traumatismes crâniens
Le grand nombre de médicaments en cours de développement et d'approbation de nouveaux médicaments est le principal facteur de croissance du marché mondial des traumatismes crâniens. En raison de la prévalence croissante des traumatismes crâniens (TCC), le nombre de médicaments en cours de développement pour leur traitement augmente à un rythme significatif. La plupart des médicaments qui en sont aux dernières phases de développement devraient obtenir une autorisation de mise sur le marché au cours de la période de prévision. En outre, quelques médicaments en cours de développement présentent un profil d'efficacité et de sécurité décent. Une fois ces médicaments confirmés, ils augmenteront le nombre de produits sur le marché et alimenteront la croissance de la taille du marché des thérapies contre les traumatismes crâniens.
Opportunités
- Augmentation du nombre de campagnes et de programmes de sensibilisation à la santé
Le marché mondial du traitement des traumatismes crâniens présente des opportunités en raison du nombre croissant de campagnes et de programmes de sensibilisation à la santé qui ont incité les individus à mieux prendre soin de leur santé et à être plus conscients des maladies qui peuvent être provoquées par l'utilisation de divers produits. En outre, l'expansion des installations médicales dans le monde entier et les engagements financiers des secteurs public et privé ont permis au marché du traitement des traumatismes crâniens de se développer considérablement. Ces applications croissantes créeront des opportunités lucratives sur le marché, complétant ainsi la croissance du marché.
Contraintes/Défis
D'autre part, des facteurs tels que les coûts de démarrage élevés des entreprises de traitement des lésions cérébrales traumatiques empêchent de nombreux nouveaux acteurs d'entrer sur le marché. De plus, le système strict et restrictif de lois et de réglementations mis en place par les gouvernements de divers pays constitue également un obstacle majeur à la croissance du marché du traitement des lésions cérébrales traumatiques. La croissance du marché a également été entravée par le manque de connaissances du grand public sur les lésions cérébrales et leurs traitements. En outre, certains ont été découragés de recevoir un tel traitement en raison des résultats tardifs du diagnostic.
Ce rapport sur le marché du traitement des traumatismes crâniens fournit des détails sur les nouveaux développements récents, les réglementations commerciales, l'analyse des importations et des exportations, l'analyse de la production, l'optimisation de la chaîne de valeur, la part de marché, l'impact des acteurs du marché national et local, les opportunités d'analyse en termes de poches de revenus émergentes, les changements dans la réglementation du marché, l'analyse stratégique de la croissance du marché, la taille du marché, la croissance du marché des catégories, les niches d'application et la domination, les approbations de produits, les lancements de produits, les expansions géographiques, les innovations technologiques sur le marché. Pour obtenir plus d'informations sur le marché du traitement des traumatismes crâniens, contactez Data Bridge Market Research pour un briefing d'analyste, notre équipe vous aidera à prendre une décision de marché éclairée pour atteindre la croissance du marché.
Développement récent
- En août 2021, l'Arkansas Children's Hospital a accepté d'acquérir TRIUX™ neo pour l'imagerie cérébrale fonctionnelle. Cela contribuera à la capacité de détection lors du diagnostic de patients dans un large spectre, notamment l'épilepsie , les tumeurs cérébrales, les lésions cérébrales traumatiques, le syndrome de stress post-traumatique et l'autisme.
Portée du marché mondial du traitement des traumatismes crâniens
Le marché du traitement des traumatismes crâniens est segmenté en fonction du traitement, de la voie d'administration, de l'âge du patient, du sexe, de la cause de la blessure et des utilisateurs finaux. La croissance parmi ces segments vous aidera à analyser les segments de croissance faibles dans les industries et à fournir aux utilisateurs un aperçu précieux du marché et des informations sur le marché pour les aider à prendre des décisions stratégiques pour identifier les principales applications du marché.
Traitement
- Soins d'urgence immédiats
- Médicaments
- Diurétiques
- Médicaments antiépileptiques
- Médicaments provoquant le coma
- Agent anti-anxiété
- Antidépresseurs
- Antipsychotiques
- Analgésique
- Anticonvulsivant
- Anticoagulants
- Chirurgie
- Élimination du sang coagulé
- Réparation des fractures du crâne
- Traitement des saignements cérébraux
- Ouverture de fenêtre dans le crâne et rééducation
Voie d'administration
- Parentérale
- Oral
Âge du patient
- Enfants
- Adolescent
- Aîné
Genre
- Mâle
- Femelle
Cause de la blessure
- Chutes
- Circulation des véhicules à moteur
- Sportif
- Autres
Utilisateur final
- Hôpitaux
- Cliniques de neurologie
- Pharmacies indépendantes
- Autres
Analyse/perspectives du marché mondial du traitement des traumatismes crâniens
Le marché du traitement des lésions cérébrales traumatiques est analysé et des informations et tendances sur la taille du marché sont fournies par pays, traitement, voie d’administration, âge du patient, sexe, cause de blessure et utilisateurs finaux, comme référencé ci-dessus.
Les pays couverts dans le rapport sur le marché mondial du traitement des lésions cérébrales traumatiques sont les États-Unis, le Canada et le Mexique en Amérique du Nord, l'Allemagne, la France, le Royaume-Uni, les Pays-Bas, la Suisse, la Belgique, la Russie, l'Italie, l'Espagne, la Turquie, le reste de l'Europe en Europe, la Chine, le Japon, l'Inde, la Corée du Sud, Singapour, la Malaisie, l'Australie, la Thaïlande, l'Indonésie, les Philippines, le reste de l'Asie-Pacifique (APAC) en Asie-Pacifique (APAC), l'Arabie saoudite, les Émirats arabes unis, l'Afrique du Sud, l'Égypte, Israël, le reste du Moyen-Orient et de l'Afrique (MEA) en tant que partie du Moyen-Orient et de l'Afrique (MEA), le Brésil, l'Argentine et le reste de l'Amérique du Sud en tant que partie de l'Amérique du Sud.
L’Amérique du Nord devrait connaître une croissance positive en raison du volume important de la population cible et du nombre croissant de personnes souffrant de lésions cérébrales traumatiques dans cette région.
L’Asie-Pacifique devrait connaître le taux de croissance le plus élevé au cours de la période de prévision en raison de l’augmentation des cas d’accidents de la circulation et de blessures sur la route dans la région.
La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché national qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que l'analyse de la chaîne de valeur en aval et en amont, les tendances techniques et l'analyse des cinq forces de Porter, les études de cas sont quelques-uns des indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et les routes commerciales sont pris en compte tout en fournissant une analyse prévisionnelle des données nationales.
Croissance de la base installée des infrastructures de santé et pénétration des nouvelles technologies
Le marché mondial du traitement des traumatismes crâniens vous fournit également une analyse détaillée du marché pour chaque pays, la croissance des dépenses de santé pour les biens d'équipement, la base installée de différents types de produits pour le marché mondial du traitement des traumatismes crâniens, l'impact de la technologie utilisant les courbes de vie et les changements dans les scénarios réglementaires des soins de santé et leur impact sur le marché mondial du traitement des traumatismes crâniens. Les données sont disponibles pour la période historique 2015-2020.
Analyse du paysage concurrentiel et des parts de marché du traitement des traumatismes crâniens à l'échelle mondiale
Le paysage concurrentiel du marché mondial du traitement des lésions cérébrales traumatiques fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché mondial du traitement des lésions cérébrales traumatiques.
Certains des principaux acteurs opérant sur le marché mondial du traitement des traumatismes crâniens sont :
- Zimmer Biomet (États-Unis)
- Neuren Pharmaceuticals (Australie)
- Teva Pharmaceutical Industries Ltd. (Israël)
- Medicortex Finland Oy (Finlande)
- AMARANTUS BIOSCIENCE HOLDINGS, INC. (ÉTATS-UNIS)
- Stemedica Cell Technologies, Inc. (États-Unis)
- BANYAN BIOMARKERS, INC. (États-Unis)
- BioDirection (États-Unis)
- QuesGen Systems, Inc. (États-Unis)
- Neural Analytics, Inc. (États-Unis)
- Oculogica, VASOPHARM (États-Unis)
- Johnson & Johnson Services Inc. (États-Unis)
- Smith & Nephew (Royaume-Uni)
- Stryker (États-Unis)
- Medtronic (États-Unis)
- Bioretec Ltd. (Finlande)
- B. Braun Melsungen AG (Allemagne)
- Arthrex, Inc. (États-Unis)
- Wright Medical Group NV (États-Unis)
- NuVasive Inc. (États-Unis)
- Solutions orthopédiques avancées (États-Unis)
- Arthrosurface (États-Unis)
- CONMED Corporation (U.S.)
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 MARKET END-USER COVERAGE GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
4.3 TECHNOLOGY ROADMAP
4.4 VALUE CHAIN ANALYSIS
4.5 OPPUTUNITY MAP ANALYSIS
4.6 REIMBURSEMENT FRAMEWORK
4.7 COST ANALYSIS BREAKDOWN
4.8 PENETRATION AND GROWTH PROSPECT MAPPING: GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET
4.9 KEY PRICING STRATEGIES: GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET
4.1 MICRO AND MACRO-ECONOMIC FACTORS: GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET
5 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET, REGULATORY FRAMEWORK
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING INCIDENCE OF TRAUMATIC BRAIN INJURY (TBI)
6.1.2 GROWING ADOPTION OF MINIMALLY INVASIVE PROCEDURES IN TBI TREATMENT
6.1.3 TECHNOLOGICAL ADVANCEMENT FOR DIAGNOSIS OF TRAUMATIC BRAIN INJURIES (TBI)
6.1.4 ADVANCEMENTS IN NEUROPROTECTION AND PHARMACOTHERAPY FOR TBI TREATMENT
6.2 RESTRAINTS
6.2.1 SHORTAGE OF TRAINED NEUROLOGISTS AND NEUROSURGEONS
6.2.2 HIGH COST OF TRAUMATIC BRAIN INJURY (TBI) TREATMENT
6.3 OPPORTUNITIES
6.3.1 RISING PERSONALIZED & TARGETED THERAPIES IN TRAUMATIC BRAIN INJURY (TBI)
6.3.2 GROWING BRAIN STIMULATION TECHNIQUES IN TRAUMATIC BRAIN INJURY (TBI) TREATMENT
6.3.3 RISING ARTIFICIAL INTELLIGENCE (AI) APPLICATIONS IN DIAGNOSING TRAUMATIC BRAIN INJURY (TBI)
6.4 CHALLENGES
6.4.1 DIFFICULTIES IN OVERCOMING THE BLOOD-BRAIN BARRIER FOR TBI TREATMENT
6.4.2 ABSENCE OF STANDARDIZED TREATMENT PROTOCOLS IN TRAUMATIC BRAIN INJURY MANAGEMENT
7 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT
7.1 OVERVIEW
7.2 SURGERY
7.2.1 BRAIN BLEEDING TREATMENT
7.2.2 REHABILITATION
7.2.3 CLOTTED BLOOD REMOVAL
7.2.4 WINDOW OPENING IN SKULL
7.2.5 REPAIRING SKULL FRACTURES
7.3 IMMEDIATE EMERGENCY CARE
7.4 MEDICATIONS
7.4.1 DIURETICS
7.4.2 ANTI-SEIZURE DRUGS (ANTI-CONVULSANT)
7.4.3 ANALGESIC
7.4.4 COMA-INDUCING DRUGS
7.4.5 ANTI-DEPRESSANTS
7.4.6 ANTI-ANXIETY AGENT
7.4.7 ANTI-PSYCHOTICS
7.4.8 ANTI-COAGULANTS
7.4.9 OTHERS
7.4.9.1 PARENTERAL
7.4.9.2 ORAL
7.4.9.3 OTHERS
8 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE
8.1 OVERVIEW
8.2 CHILDREN
8.3 TEENAGER
8.4 ELDER
9 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER
9.1 OVERVIEW
9.2 MALE
9.3 FEMALE
10 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET, CAUSE OF INJURY
10.1 OVERVIEW
10.2 FALLS
10.3 MOTOR VEHICLE TRAFFIC
10.4 SPORTS
10.5 OTHERS
11 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITALS
11.3 NEUROLOGY CLINICS
11.4 INDEPENDENT PHARMACIES
11.5 OTHERS
12 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION
12.1 OVERVIEW
12.2 NORTH AMERICA
12.2.1 U.S.
12.2.2 CANADA
12.2.3 MEXICO
12.3 EUROPE
12.3.1 GERMANY
12.3.2 U.K.
12.3.3 FRANCE
12.3.4 ITALY
12.3.5 SPAIN
12.3.6 RUSSIA
12.3.7 NETHERLANDS
12.3.8 SWITZERLAND
12.3.9 TURKEY
12.3.10 BELGIUM
12.3.11 REST OF EUROPE
12.4 ASIA-PACIFIC
12.4.1 CHINA
12.4.2 JAPAN
12.4.3 INDIA
12.4.4 SOUTH KOREA
12.4.5 AUSTRALIA
12.4.6 SINGAPORE
12.4.7 THAILAND
12.4.8 MALAYSIA
12.4.9 INDONESIA
12.4.10 TAIWAN
12.4.11 NEW ZEALAND
12.4.12 PHILIPPINES
12.4.13 VIETNAM
12.4.14 REST OF ASIA-PACIFIC
12.5 MIDDLE EAST AND AFRICA
12.5.1 SOUTH AFRICA
12.5.2 SAUDI ARABIA
12.5.3 U.A.E.
12.5.4 EGYPT
12.5.5 ISRAEL
12.5.6 REST OF MIDDLE EAST AND AFRICA
12.6 SOUTH AMERICA
12.6.1 BRAZIL
12.6.2 ARGENTINA
12.6.3 REST OF SOUTH AMERICA
13 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: GLOBAL
13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
13.3 COMPANY SHARE ANALYSIS: EUROPE
13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
14 SWOT ANALYSIS
15 COMPANY PROFILES
15.1 PFIZER INC.
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENT
15.2 TEVA PHARMACEUTICALS USA, INC.
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENT/NEWS
15.3 FRESENIUS SE & CO. KGAA (FRESENIUS KABI AG)
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENT
15.4 VIATRIS INC.
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENT
15.5 AMNEAL PHARMACEUTICALS LLC
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENT
15.6 ADVACARE PHARMA
15.6.1 COMPANY SNAPSHOT
15.6.2 PRODUCT PORTFOLIO
15.6.3 RECENT DEVELOPMENT
15.7 AUROBINDO PHARMA LIMITED
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENT
15.8 ALEMBIC PHARMACEUTICALS LIMITED
15.8.1 COMPANY SNAPSHOT
15.8.2 REVENUE ANALYSIS
15.8.3 PRODUCT PORTFOLIO
15.8.4 RECENT DEVELOPMENT
15.9 B. BRAUN SE
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT UPDATES
15.1 DR. REDDY’S LABORATORIES LTD.
15.10.1 COMPANY SNAPSHOT
15.10.2 REVENUE ANALYSIS
15.10.3 PIPELINE PRODUCT PORTFOLIO
15.10.4 RECENT DEVELOPMENT
15.11 ICU MEDICAL, INC.
15.11.1 COMPANY SNAPSHOT
15.11.2 REVENUE ANALYSIS
15.11.3 PRODUCT PORTFOLIO
15.11.4 RECENT DEVELOPMENT/NEWS
15.12 HIKMA PHARMACEUTICALS PLC
15.12.1 COMPANY SNAPSHOT
15.12.2 REVENUE ANALYSIS
15.12.3 PIPELINE PRODUCT PORTFOLIO
15.12.4 RECENT DEVELOPMENT
15.13 JEDUX PARENTERAL PRIVATE LIMITED
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENT
15.14 LUPIN
15.14.1 COMPANY SNAPSHOT
15.14.2 REVENUE ANALYSIS
15.14.3 PRODUCT PORTFOLIO
15.14.4 RECENT DEVELOPMENT
15.15 MERZ THERAPEUTICS
15.15.1 COMPANY SNAPSHOT
15.15.2 PIPELINE PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENT
15.16 MAXZIMAA
15.16.1 COMPANY SNAPSHOT
15.16.2 PIPELINE PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENT
15.17 SUN PHARMACEUTICAL INDUSTRIES LTD.
15.17.1 COMPANY SNAPSHOT
15.17.2 REVENUE ANALYSIS
15.17.3 PRODUCT PORTFOLIO
15.17.4 RECENT DEVELOPMENT
15.18 SWISS PHARMA NIGERIA LIMITED
15.18.1 COMPANY SNAPSHOT
15.18.2 PRODUCT PORTFOLIO
15.18.3 RECENT DEVELOPMENT
15.19 SAGENT
15.19.1 COMPANY SNAPSHOT
15.19.2 PRODUCT PORTFOLIO
15.19.3 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
Liste des tableaux
TABLE 1 NON-INVASIVE THERAPEUTIC APPROACHES’ EFFICIENCY IN DIFFERENT PHASES OF TBI
TABLE 2 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 3 GLOBAL SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 4 GLOBAL SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 5 GLOBAL IMMEDIATE EMERGENCY CARE IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 6 GLOBAL MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 7 GLOBAL MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 8 GLOBAL MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 9 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 10 GLOBAL CHILDREN IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 11 GLOBAL TEENAGER IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 12 GLOBAL ELDER IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 13 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 14 GLOBAL MALE IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 15 GLOBAL FEMALE IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 16 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 17 GLOBAL FALLS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 18 GLOBAL MOTOR VEHICLE TRAFFIC IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 19 GLOBAL SPORTS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 20 GLOBAL OTHERS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 21 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 22 GLOBAL HOSPITALS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 23 GLOBAL NEUROLOGY CLINICS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 24 GLOBAL INDEPENDENT PHARMACIES IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 25 GLOBAL OTHERS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 26 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 27 NORTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 28 NORTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 29 NORTH AMERICA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 30 NORTH AMERICA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 31 NORTH AMERICA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 32 NORTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 33 NORTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 34 NORTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 35 NORTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 36 U.S. TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 37 U.S. SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 38 U.S. MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 39 U.S. MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 40 U.S. TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 41 U.S. TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 42 U.S. TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 43 U.S. TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 44 CANADA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 45 CANADA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 46 CANADA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 47 CANADA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 48 CANADA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 49 CANADA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 50 CANADA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 51 CANADA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 52 MEXICO TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 53 EUROPE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 54 EUROPE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 55 EUROPE SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 56 EUROPE MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 57 EUROPE MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 58 EUROPE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 59 EUROPE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 60 EUROPE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 61 EUROPE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 62 GERMANY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 63 GERMANY SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 64 GERMANY MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 65 GERMANY MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 66 GERMANY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 67 GERMANY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 68 GERMANY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 69 GERMANY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 70 U.K. TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 71 U.K. SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 72 U.K. MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 73 U.K. MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 74 U.K. TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 75 U.K. TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 76 U.K. TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 77 U.K. TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 78 FRANCE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 79 FRANCE SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 80 FRANCE MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 81 FRANCE MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 82 FRANCE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 83 FRANCE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 84 FRANCE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 85 FRANCE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 86 ITALY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 87 ITALY SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 88 ITALY MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 89 ITALY MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 90 ITALY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 91 ITALY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 92 ITALY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 93 ITALY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 94 SPAIN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 95 SPAIN SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 96 SPAIN MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 97 SPAIN MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 98 SPAIN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 99 SPAIN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 100 SPAIN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 101 SPAIN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 102 RUSSIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 103 RUSSIA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 104 RUSSIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 105 RUSSIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 106 RUSSIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 107 RUSSIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 108 RUSSIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 109 RUSSIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 110 NETHERLANDS TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 111 NETHERLANDS SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 112 NETHERLANDS MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 113 NETHERLANDS MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 114 NETHERLANDS TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 115 NETHERLANDS TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 116 NETHERLANDS TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 117 NETHERLANDS TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 118 SWITZERLAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 119 SWITZERLAND SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 120 SWITZERLAND MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 121 SWITZERLAND MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 122 SWITZERLAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 123 SWITZERLAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 124 SWITZERLAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 125 SWITZERLAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 126 TURKEY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 127 TURKEY SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 128 TURKEY MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 129 TURKEY MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 130 TURKEY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 131 TURKEY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 132 TURKEY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 133 TURKEY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 134 BELGIUM TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 135 BELGIUM SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 136 BELGIUM MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 137 BELGIUM MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 138 BELGIUM TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 139 BELGIUM TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 140 BELGIUM TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 141 BELGIUM TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 142 REST OF EUROPE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 143 ASIA-PACIFIC TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 144 ASIA-PACIFIC TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 145 ASIA-PACIFIC SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 146 ASIA-PACIFIC MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 147 ASIA-PACIFIC MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 148 ASIA-PACIFIC TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 149 ASIA-PACIFIC TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 150 ASIA-PACIFIC TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 151 ASIA-PACIFIC TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 152 CHINA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 153 CHINA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 154 CHINA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 155 CHINA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 156 CHINA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 157 CHINA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 158 CHINA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 159 CHINA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 160 JAPAN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 161 JAPAN SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 162 JAPAN MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 163 JAPAN MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 164 JAPAN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 165 JAPAN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 166 JAPAN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 167 JAPAN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 168 INDIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 169 INDIA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 170 INDIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 171 INDIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 172 INDIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 173 INDIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 174 INDIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 175 INDIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 176 SOUTH KOREA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 177 SOUTH KOREA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 178 SOUTH KOREA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 179 SOUTH KOREA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 180 SOUTH KOREA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 181 SOUTH KOREA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 182 SOUTH KOREA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 183 SOUTH KOREA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 184 AUSTRALIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 185 AUSTRALIA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 186 AUSTRALIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 187 AUSTRALIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 188 AUSTRALIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 189 AUSTRALIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 190 AUSTRALIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 191 AUSTRALIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 192 SINGAPORE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 193 SINGAPORE SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 194 SINGAPORE MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 195 SINGAPORE MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 196 SINGAPORE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 197 SINGAPORE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 198 SINGAPORE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 199 SINGAPORE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 200 THAILAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 201 THAILAND SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 202 THAILAND MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 203 THAILAND MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 204 THAILAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 205 THAILAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 206 THAILAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 207 THAILAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 208 MALAYSIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 209 MALAYSIA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 210 MALAYSIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 211 MALAYSIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 212 MALAYSIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 213 MALAYSIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 214 MALAYSIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 215 MALAYSIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 216 INDONESIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 217 INDONESIA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 218 INDONESIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 219 INDONESIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 220 INDONESIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 221 INDONESIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 222 INDONESIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 223 INDONESIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 224 TAIWAN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 225 TAIWAN SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 226 TAIWAN MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 227 TAIWAN MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 228 TAIWAN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 229 TAIWAN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 230 TAIWAN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 231 TAIWAN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 232 NEW ZEALAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 233 NEW ZEALAND SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 234 NEW ZEALAND MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 235 NEW ZEALAND MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 236 NEW ZEALAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 237 NEW ZEALAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 238 NEW ZEALAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 239 NEW ZEALAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 240 PHILIPPINES TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 241 PHILIPPINES SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 242 PHILIPPINES MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 243 PHILIPPINES MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 244 PHILIPPINES TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 245 PHILIPPINES TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 246 PHILIPPINES TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 247 PHILIPPINES TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 248 VIETNAM TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 249 VIETNAM SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 250 VIETNAM MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 251 VIETNAM MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 252 VIETNAM TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 253 VIETNAM TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 254 VIETNAM TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 255 VIETNAM TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 256 REST OF ASIA-PACIFIC TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 257 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 258 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 259 MIDDLE EAST AND AFRICA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 260 MIDDLE EAST AND AFRICA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 261 MIDDLE EAST AND AFRICA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 262 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 263 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 264 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 265 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 266 SOUTH AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 267 SOUTH AFRICA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 268 SOUTH AFRICA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 269 SOUTH AFRICA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 270 SOUTH AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 271 SOUTH AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 272 SOUTH AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 273 SOUTH AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 274 SAUDI ARABIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 275 SAUDI ARABIA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 276 SAUDI ARABIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 277 SAUDI ARABIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 278 SAUDI ARABIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 279 SAUDI ARABIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 280 SAUDI ARABIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 281 SAUDI ARABIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 282 U.A.E TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 283 U.A.E SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 284 U.A.E MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 285 U.A.E MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 286 U.A.E TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 287 U.A.E TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 288 U.A.E TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 289 U.A.E TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 290 EGYPT TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 291 EGYPT SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 292 EGYPT MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 293 EGYPT MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 294 EGYPT TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 295 EGYPT TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 296 EGYPT TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 297 EGYPT TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 298 ISRAEL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 299 ISRAEL SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 300 ISRAEL MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 301 ISRAEL MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 302 ISRAEL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 303 ISRAEL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 304 ISRAEL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 305 ISRAEL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 306 REST OF MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 307 SOUTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 308 SOUTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 309 SOUTH AMERICA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 310 SOUTH AMERICA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 311 SOUTH AMERICA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 312 SOUTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 313 SOUTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 314 SOUTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 315 SOUTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 316 BRAZIL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 317 BRAZIL SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 318 BRAZIL MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 319 BRAZIL MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 320 BRAZIL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 321 BRAZIL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 322 BRAZIL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 323 BRAZIL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 324 ARGENTINA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 325 ARGENTINA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 326 ARGENTINA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 327 ARGENTINA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 328 ARGENTINA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 329 ARGENTINA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 330 ARGENTINA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 331 ARGENTINA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 332 REST OF SOUTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
Liste des figures
FIGURE 1 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: SEGMENTATION
FIGURE 2 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 8 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: MARKET END-USER COVERAGE GRID
FIGURE 9 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: SEGMENTATION
FIGURE 11 INCREASING INCIDENCE OF TRAUMATIC BRAIN INJURY (TBI) IS EXPECTED TO DRIVE THE GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET GROWTH IN THE FORECAST PERIOD OF 2025 TO 2032
FIGURE 12 SURGERY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET IN THE FORECAST PERIOD OF 2025 & 2032
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2025 TO 2032
FIGURE 14 ASIA-PACIFIC IS THE FASTEST-GROWING MARKET FOR GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET IN THE FORECAST PERIOD OF 2025 TO 2032
FIGURE 15 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: EXECUTIVE SUMMARY
FIGURE 16 STRATEGIC DECISIONS
FIGURE 17 DROC ANALYSIS
FIGURE 18 TBI-RELATED DEATHS FROM 2018 TO 2024
FIGURE 19 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY TREATMENT, 2024
FIGURE 20 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY TREATMENT, 2025 TO 2032 (USD THOUSAND)
FIGURE 21 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY TREATMENT, CAGR (2025- 2032)
FIGURE 22 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY TREATMENT, LIFELINE CURVE
FIGURE 23 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY PATIENT AGE, 2024
FIGURE 24 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY PATIENT AGE, 2025 TO 2032 (USD THOUSAND)
FIGURE 25 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY PATIENT AGE, CAGR (2025- 2032)
FIGURE 26 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY PATIENT AGE, LIFELINE CURVE
FIGURE 27 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY GENDER, 2024
FIGURE 28 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY GENDER, 2025-2032 (USD THOUSAND)
FIGURE 29 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY GENDER CAGR (2025-2032)
FIGURE 30 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY GENDER, LIFELINE CURVE
FIGURE 31 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY CAUSE OF INJURY, 2024
FIGURE 32 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY CAUSE OF INJURY, 2025-2032 (USD THOUSAND)
FIGURE 33 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY CAUSE OF INJURY, CAGR (2025-2032)
FIGURE 34 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY CAUSE OF INJURY, LIFELINE CURVE
FIGURE 35 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY END USER, 2024
FIGURE 36 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY END USER, 2025-2032 (USD THOUSAND)
FIGURE 37 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY END USER, CAGR (2025-2032)
FIGURE 38 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY END USER, LIFELINE CURVE
FIGURE 39 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: SNAPSHOT (2024)
FIGURE 40 GLOBAL TRAUMATIC BRAIN INJURY TREATMENT MARKET: COMPANY SHARE 2024 (%)
FIGURE 41 NORTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: COMPANY SHARE 2024 (%)
FIGURE 42 EUROPE TRAUMATIC BRAIN INJURY TREATMENT MARKET: COMPANY SHARE 2024 (%)
FIGURE 43 ASIA-PACIFIC TRAUMATIC BRAIN INJURY TREATMENT MARKET: COMPANY SHARE 2024 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
